Previous results from our laboratory demonstrated, in SCID mice, inhibitory effects of the Nef-M1 peptide on the growth of primary CRC xenografts generated from fresh surgical specimens of human CRCs. This evidence concerns the gene S100B and colorectal carcinoma.